Anheuser-Busch InBev SA/NV BUD
86.05 USD +0.96 (+1.13%)
At closeNov 11, 2026, 6:16 AM EST
84.13 -1.92 -2.23%
Pre-market · Nov 11, 6:16 AM ET
85.19 Day range 86.31
59.90 52-week range 86.60
- YTD
- +34.37%
- 1 year
- +35.83%
News
defenseworld.net Head-To-Head Analysis: Anheuser-Busch InBev SA/NV (NYSE:BUD) & Ambev (NYSE:ABEV) Anheuser-Busch InBev SA/NV (NYSE: BUD - Get Free Report) and Ambev (NYSE: ABEV - Get Free Report) are both large-cap consumer staples companies, but which is the better business? We will compare the…
benzinga.com Hoping For Cheaper Beer? Budweiser Parent Signals No Retreat From Inflation-Based Pricing AB InBev stock fell despite beating Q3 earnings and revenue estimates, weighed down by margin compression and weak sales in China.
benzinga.com Anheuser-Busch InBev Q3 2026 Earnings Call Transcript Anheuser-Busch InBev (NYSE:BUD) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought…
benzinga.com What's Going On With Ambev Stock Thursday? Ambev (ABEV) stock dips despite beating Q3 revenue estimates at $4.2B. Read the full breakdown of earnings, profit, and buyback plans.
benzinga.com AB InBev Guides FY26 EBITDA Growth To 4-8%, Quarterly Net Finance Costs To $190M-$220M, Net Capex To $3.5B-$4.0B, Excluding Tax Legislation Changes 2026 Outlook(i) Overall Performance: We expect our EBITDA to grow in line with our medium-term outlook of between 4-8%. The outlook for FY26 reflects our current assessment of inflation and other…
benzinga.com Anheuser-Busch InBev Q3 Adj. EPS $1.21 Beats $1.15 Estimate, Sales $16.512B Beat $16.292B Estimate Anheuser-Busch InBev (NYSE:BUD) reported quarterly earnings of $1.21 per share which beat the analyst consensus estimate of $1.15 by 5.22 percent. This is a 22.22 percent increase over earnings of…
benzinga.com Amazon, Eli Lilly On Deck Thursday As AWS Growth, Drug Demand Face Test Amazon headlines Thursday’s reports, with investors focused on whether accelerating AWS growth and heavy AI spending can support the next leg of its expansion. Eli Lilly, Mastercard, Merck,…- benzinga.com TD Cowen Maintains Hold on Anheuser-Busch InBev, Lowers Price Target to $85 TD Cowen analyst Robert Moskow maintains Anheuser-Busch InBev (NYSE:BUD) with a Hold and lowers the price target from $89 to $85.